Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Corporacion Financiera Alba SA (ES:ALB)
BME:ALB
Corporacion Financiera Alba (ALB) Stock Price & Analysis
1 Followers
ALB Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€44.56 - €51.60
Previous Close€47.5
Volume31.00
Average Volume (3M)4.48K
Market Cap
€2.86B
Enterprise Value€3.60B
Total Cash (Recent Filing)€0.00
Total Debt (Recent Filing)€617.60M
Price to Earnings (P/E)12.2
Beta0.46
Next Earnings
Feb 28, 2024EPS EstimateN/A
Last Dividend Ex-Date
Jun 22, 2023Dividend Yield3.32%
Share Statistics
EPS (TTM)3.92
Shares OutstandingN/A
10 Day Avg. Volume3,485
30 Day Avg. Volume4,482
Standard Deviation0.06
R-Squared0.42
Alpha0.00050
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Corporacion Financiera Alba News
Options Prices
Currently, No data available
---
Ownership Overview
53.44% Insiders
0.52% Mutual Funds
<0.01% Other Institutional Investors
46.04% Public Companies and
Individual Investors
ALB FAQ
What was Corporacion Financiera Alba SA’s price range in the past 12 months?
Corporacion Financiera Alba SA lowest stock price was €44.56 and its highest was €51.60 in the past 12 months.
What is Corporacion Financiera Alba SA’s market cap?
Currently, no data Available
When is Corporacion Financiera Alba SA’s upcoming earnings report date?
Corporacion Financiera Alba SA’s upcoming earnings report date is Feb 28, 2024 which is 65 days ago.
How were Corporacion Financiera Alba SA’s earnings last quarter?
Corporacion Financiera Alba SA released its earnings results on Sep 25, 2023. The company reported €2.48 earnings per share for the quarter, beating the consensus estimate of N/A by €2.48.
Is Corporacion Financiera Alba SA overvalued?
According to Wall Street analysts Corporacion Financiera Alba SA’s price is currently Overvalued.
Does Corporacion Financiera Alba SA pay dividends?
Corporacion Financiera Alba SA pays a Semiannually dividend of €0.78 which represents an annual dividend yield of 3.32%. See more information on Corporacion Financiera Alba SA dividends here
What is Corporacion Financiera Alba SA’s EPS estimate?
Corporacion Financiera Alba SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Corporacion Financiera Alba SA have?
Corporacion Financiera Alba SA has 60,305,187 shares outstanding.
What happened to Corporacion Financiera Alba SA’s price movement after its last earnings report?
Corporacion Financiera Alba SA reported an EPS of €2.48 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -0.412%.
Which hedge fund is a major shareholder of Corporacion Financiera Alba SA?
Currently, no hedge funds are holding shares in ES:ALB
---
Corporacion Financiera Alba Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Fundamentals
Return on Equity
5.08%
Trailing 12-Months
Asset Growth
1.25%
Trailing 12-Months
Company Description
Corporacion Financiera Alba SA
Corporacion Financiera Alba SA is an investment holding company in Spain. Its investments include top-tier office buildings in prime downtown and suburban business locations. The firms business is based on the rent operation of these buildings. It seeks to optimize their value and manages their commercial, administrative and technical aspects of financial real estate activities. The company pays special attention to the maintenance, upkeep and improvement of these buildings. It strongly focuses on the office markets of Barcelona and Madrid cities. The company is a part of March group which integrates Banca March and Fundacion Juan March. Its current investment portfolio includes Acerinox, ACS, Clinica baviera, Ebro, Indra, Viscofan.
---
Technical Analysis
---